COMP <GO>
UROY vs JPM // EV/EBITDA & P/E VALUATION
Uranium Royalty Corp. (NASDAQ) VS. JPMorgan Chase & Co. (NYSE) • 15-METRIC TALLY: UROY 2
— JPM 5
▲ EV/EBITDA & P/E VALUATION LEADER: JPM
LAST: $3.47 (-2.80%) • MKT CAP: $1.31B
valuation
27.1x
LAST: $343.58 (+1.26%) • MKT CAP: $913.30B
valuation
9.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UROY VS. JPM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UROY | JPM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 17.37% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 27.1x | 9.7x | +17.43 | JPM | /valuation <GO> |
| Free Cash Flow Yield | 13.63% | -18.14% | +31.77 | UROY | /fcf-yield <GO> |
| Operating Margin | — | 42.07% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 32.63% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 13.53% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.96% | -1.96 | JPM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 2/9 | +3.00 | UROY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 4.84% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.3 | 55.1 | -18.79 | JPM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.00 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.2x | 13.6x | +16.63 | JPM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.31B | $913.30B | -$911.99B | JPM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UROY REV | JPM REV | UROY GROSS % | JPM GROSS % | UROY FCF | JPM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $182.45B | — | — | $178.5M | -$147.78B |
| FY 2024 | $0 | $177.56B | — | — | -$15.1M | -$42.01B |
| FY 2023 | $0 | $158.10B | — | — | -$76.4M | $12.97B |
| FY 2022 | — | $128.69B | — | — | — | $107.12B |
| FY 2021 | — | $121.65B | — | — | — | $78.08B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UROY // BETA —
JPM // BETA 1.00